Peter Salzmann's Net Worth
$41.1 Million
Who is Peter Salzmann?
Peter Salzmann has an estimated net worth of $41.1 Million. This is based on reported shares across multiple companies, which include Immunovant, Inc., and Corbus Pharmaceuticals Holdings, Inc..
SEC CIK
Peter Salzmann's CIK is 0001796309
Past Insider Trading and Trends
2021 was Peter Salzmann's most active year for acquiring shares with 7 total transactions. Peter Salzmann's most active month to acquire stocks was the month of April. 2023 was Peter Salzmann's most active year for disposing of shares, totalling 12 transactions. Peter Salzmann's most active month to dispose stocks was the month of July. 2019 saw Peter Salzmann paying a total of $0.00 for 1,479,043 shares, this is the most they've acquired in one year. In 2023 Peter Salzmann cashed out on 293,276 shares for a total of $6,564,261.77, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Immunovant, Inc. (IMVT) Snapshot price: $35.28
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -3.14% | -34.08K |
$29.06 | -$990,269.16 | 1.05M |
Apr 17
| |||
Form 4
| -0.44% | -4.81K |
$31.18 | -$149,882.26 | 1.09M |
Apr 9
| |||
Form 4
| +17.24% | 160.53K |
—
|
—
| 1.09M |
Apr 2
| |||
Form 4
| -1.42% | -13.45K |
$36.15 | -$486,362.10 | 931.23K |
Feb 22
| |||
Form 4
| -0.40% | -3.82K |
$38.59 | -$147,568.16 | 944.68K |
Jan 5
| |||
Form 4
| -1.68% | -16.22K |
$32.78 | -$531,581.07 | 948.51K |
Nov 22
| |||
Form 4
| -0.54% | -5.24K |
$36.24 | -$189,887.31 | 964.73K |
Oct 5
| |||
Form 4
| -5.53% | -56.77K |
$22.02 | -$1,250,337.86 | 969.97K |
Aug 30
| |||
Form 4
| -9.12% | -103.06K |
$21.42 | -$2,207,177.52 | 1.03M |
Aug 14
| |||
Form 4
| -8.23% | -101.34K |
$21.73 | -$2,202,096.47 | 1.13M |
Aug 7
| |||
Form 4
| -0.26% | -3.23K |
$19.73 | -$63,787.09 | 1.23M |
Jul 12
| |||
Form 4
| -0.27% | -3.40K |
$15.27 | -$51,841.65 | 1.23M |
Apr 18
| |||
Form 4
| +24.53% | 243.83K |
—
|
—
| 1.24M |
Apr 12
| |||
Form 4
| -0.40% | -4.02K |
$16.80 | -$67,552.80 | 993.93K |
Jan 11
| |||
Form 4
| -0.28% | -2.79K |
$9.18 | -$25,639.74 | 1M |
Oct 13
| |||
Form 4
| -0.16% | -1.60K |
$4.67 | -$7,495.35 | 1M |
Sep 28
| |||
Form 4
| -0.16% | -1.64K |
$5.83 | -$9,584.52 | 1M |
Aug 30
| |||
Form 4
| +81.64% | 451.26K |
—
|
—
| 1M |
Aug 17
| |||
Form 4
| -0.28% | -1.53K |
$4.27 | -$6,524.56 | 552.73K |
Jul 27
| |||
Form 4
| -0.25% | -1.38K |
$4.02 | -$5,531.52 | 554.26K |
Jun 29
| |||
Form 4
| -0.26% | -1.47K |
$3.79 | -$5,575.09 | 555.63K |
May 24
| |||
Form 4
| -0.29% | -1.62K |
$4.72 | -$7,655.84 | 557.11K |
Apr 27
| |||
Form 4
| -3.33% | -19.23K |
$5.90 | -$113,439.30 | 558.73K |
Mar 24
| |||
Form 4
| -17.80% | -125.16K |
$7.25 | -$907,395.50 | 577.96K |
Jan 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 11
| |||
Form 4
| +430.65% | 570.61K |
—
|
—
| 703.11K |
Aug 3
| |||
Form 4
|
∞
| 132.5K |
—
|
—
| 132.5K |
Mar 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Corbus Pharmaceuticals Holdings, Inc. (CRBP) Snapshot price: $25.37
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||